Qilu pharmaceutical is a large-scale comprehensive modern pharmaceutical enterprise in China, specializing in the research, production and sales of preparations and APIs for the treatment of tumor, cardio cerebrovascular, anti infection, mental system, nervous system and ophthalmic diseases. The company always adheres to the innovative development strategy, takes market demand as the core, product innovation as the guide, extensively expands domestic and foreign scientific research and development cooperation, pays attention to the introduction and training of talents, builds a high-quality scientific research team, has professional and efficient research and development ability, has developed nearly 100 national level new drugs successively, and establishes a reasonable research and production for the future development of the company Product line, a number of studies were awarded national and provincial science and technology progress awards, and created good social benefits.

Qilu pharmaceutical and Zhonghui pharmaceutical package are partners for many years. On April 18, 2018, four experts from Qilu pharmaceutical went to Zhonghui pharmaceutical package for on-site audit, aiming to strengthen the in-depth cooperation between the two sides, hoping to improve product quality and build a safety barrier for human health through the joint efforts of both sides.